Evidence map›Paper›PMID 25569183›Full record

ArticleNature communications2015

A genome-wide association study of marginal zone lymphoma shows association to the HLA region.

Joseph Vijai, Zhaoming Wang, Sonja I Berndt, Christine F Skibola, Susan L Slager, Silvia de Sanjose, Mads Melbye, Bengt Glimelius, Paige M Bracci, Lucia Conde and 92 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

102 authors at 20 institutions in 14 countries.

Joseph VijaiDepartment of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Zhaoming WangCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Gaithersburg, Maryland 20877, USA.
Sonja I BerndtDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA.
Christine F Skibola1] Department of Epidemiology, School of Public Health and Comprehensive Cancer Center, Birmingham, Alabama 35233, USA [2] Division of Environmental Health Sciences, University of California Berkeley School of Public Health, Berkeley, California 94720, USA.
Susan L SlagerDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA.
Silvia de Sanjose1] Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Institut Catala d'Oncologia, IDIBELL, Barcelona 8907, Spain [2] Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona 8036, Spain.
Mads Melbye1] Department of Epidemiology Research, Division of Health Surveillance and Research, Statens Serum Institut, Copenhagen 2300, Denmark [2] Department of Medicine, Stanford University School of Medicine, Stanford, California 94305, USA.
Bengt Glimelius1] Department of Oncology and Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm 17176, Sweden [2] Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala 75105, Sweden.
Paige M BracciDepartment of Epidemiology &Biostatistics, University of California San Francisco, San Francisco, California 94118, USA.
Lucia Conde1] Department of Epidemiology, School of Public Health and Comprehensive Cancer Center, Birmingham, Alabama 35233, USA [2] Division of Environmental Health Sciences, University of California Berkeley School of Public Health, Berkeley, California 94720, USA.
Brenda M BirmannChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
Sophia S WangDepartment of Cancer Etiology, City of Hope Beckman Research Institute, Duarte, California 91030, USA.
Angela R Brooks-Wilson1] Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada V5Z1L3 [2] Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada V5A1S6.
Qing LanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA.
Paul I W de Bakker1] Department of Medical Genetics, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht 3584 CG, The Netherlands [2] Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht 3584 CX, The Netherlands.
Roel C H Vermeulen1] Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht 3584 CX, The Netherlands [2] Institute for Risk Assessment Sciences, Utrecht University, Utrecht 3508 TD, The Netherlands.
Carol PortlockDepartment of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Stephen M AnsellDepartment of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
Brian K LinkDepartment of Internal Medicine, Carver College of Medicine, The University of Iowa, Iowa City, Iowa 52242, USA.
Jacques Riby1] Department of Epidemiology, School of Public Health and Comprehensive Cancer Center, Birmingham, Alabama 35233, USA [2] Division of Environmental Health Sciences, University of California Berkeley School of Public Health, Berkeley, California 94720, USA.
Kari E North1] Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA [2] Carolina Center for Genome Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
Jian GuDepartment of Epidemiology, M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
Henrik HjalgrimDepartment of Epidemiology Research, Division of Health Surveillance and Research, Statens Serum Institut, Copenhagen 2300, Denmark.
Wendy Cozen1] Department of Preventive Medicine, USC Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA [2] Norris Comprehensive Cancer Center, USC Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA.
Nikolaus BeckerDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
Lauren R TerasEpidemiology Research Program, American Cancer Society, Atlanta, Georgia 30303, USA.
John J Spinelli1] Cancer Control Research, BC Cancer Agency, Vancouver, British Columbia, Canada V5Z1L3 [2] School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada V6T1Z3.
Jenny Turner1] Pathology, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [2] Department of Histopathology, Douglass Hanly Moir Pathology, Macquarie Park, New South Wales 2113, Australia.
Yawei ZhangDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut 06520, USA.
Mark P PurdueDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA.
Graham G Giles1] Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria 3053, Australia [2] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Carlton, Victoria 3010, Australia.
Rachel S KellyMRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London W2 1PG, UK.
Anne Zeleniuch-Jacquotte1] Department of Population Health, New York University School of Medicine, New York, New York 10016, USA [2] Cancer Institute, New York University School of Medicine, New York, New York 10016, USA.
Maria Grazia EnnasDepartment of Biomedical Science, University of Cagliari, Monserrato, Cagliari 09042, Italy.
Alain Monnereau1] Environmental Epidemiology of Cancer Group, Inserm, Centre for research in Epidemiology and Population Health (CESP), U1018, Villejuif F-94807, France [2] UMRS 1018, Univ Paris Sud, Villejuif F-94807, France [3] Registre des hémopathies malignes de la Gironde, Institut Bergonié, Bordeaux 33076, France.
Kimberly A Bertrand1] Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA [2] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Demetrius AlbanesDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA.
Tracy LightfootDepartment of Health Sciences, University of York, York YO10 5DD, UK.
Meredith YeagerCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Gaithersburg, Maryland 20877, USA.
Charles C ChungDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA.
Laurie BurdettCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Gaithersburg, Maryland 20877, USA.
Amy HutchinsonCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Gaithersburg, Maryland 20877, USA.
Charles LawrenceHealth Studies Sector, Westat, Rockville, Maryland 20850, USA.
Rebecca MontalvanHealth Studies Sector, Westat, Rockville, Maryland 20850, USA.
Liming Liang1] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA [2] Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Jinyan HuangDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Baoshan Ma1] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA [2] College of Information Science and Technology, Dalian Maritime University, Dalian 116026, China.
Danylo J VillanoDepartment of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Ann MariaDepartment of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Marina CorinesDepartment of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Tinu ThomasDepartment of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Anne J NovakDepartment of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
Ahmet DoganDepartments of Laboratory Medicine and Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Mark LiebowDepartment of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
Carrie A ThompsonDepartment of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
Thomas E WitzigDepartment of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
Thomas M HabermannDepartment of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
George J WeinerDepartment of Internal Medicine, Carver College of Medicine, The University of Iowa, Iowa City, Iowa 52242, USA.
Martyn T SmithDivision of Environmental Health Sciences, University of California Berkeley School of Public Health, Berkeley, California 94720, USA.
Elizabeth A HollyDepartment of Epidemiology &Biostatistics, University of California San Francisco, San Francisco, California 94118, USA.
Rebecca D JacksonDivision of Endocrinology, Diabetes and Metabolism, The Ohio State University, Columbus, Ohio 43210, USA.
Lesley F TinkerDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98117, USA.
Yuanqing YeDepartment of Epidemiology, M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
Hans-Olov Adami1] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA [2] Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden.
Karin E SmedbyDepartment of Medicine Solna, Karolinska Institutet, Stockholm 17176, Sweden.
Anneclaire J De Roos1] Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98117, USA [2] Department of Environmental and Occupational Health, Drexel University School of Public Health, Philadelphia, Pennsylvania 19104, USA.
Patricia HartgeDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA.
Lindsay M MortonDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA.
Richard K SeversonDepartment of Family Medicine and Public Health Sciences, Wayne State University, Detroit, Michigan 48201, USA.
Yolanda Benavente1] Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Institut Catala d'Oncologia, IDIBELL, Barcelona 8907, Spain [2] Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona 8036, Spain.
Paolo BoffettaThe Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.
Paul BrennanGroup of Genetic Epidemiology, Section of Genetics, International Agency for Research on Cancer, Lyon 69372, France.
Lenka ForetovaDepartment of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute and MF MU, Brno 65653, Czech Republic.
Marc MaynadieEA 4184, Registre des Hémopathies Malignes de Côte d'Or, University of Burgundy and Dijon University Hospital, Dijon 21070, France.
James McKayGenetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer, Lyon 69372, France.
Anthony StainesSchool of Nursing and Human Sciences, Dublin City University, Dublin 9, Ireland.
W Ryan DiverEpidemiology Research Program, American Cancer Society, Atlanta, Georgia 30303, USA.
Claire M VajdicPrince of Wales Clinical School, University of New South Wales, Sydney, New South Wales 2052, Australia.
Bruce K ArmstrongSydney School of Public Health, The University of Sydney, Sydney, New South Wales 2006, Australia.
Anne KrickerSydney School of Public Health, The University of Sydney, Sydney, New South Wales 2006, Australia.
Tongzhang ZhengDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut 06520, USA.
Theodore R HolfordDepartment of Biostatistics, Yale School of Public Health, New Haven, Connecticut 06520, USA.
Gianluca Severi1] Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria 3053, Australia [2] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Carlton, Victoria 3010, Australia [3] Human Genetics Foundation, Turin 10126, Italy.
Paolo Vineis1] MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London W2 1PG, UK [2] Human Genetics Foundation, Turin 10126, Italy.
Giovanni M FerriInterdisciplinary Department of Medicine, University of Bari, Bari 70124, Italy.
Rosalia RiccoDepartment of Pathological Anatomy, University of Bari, Bari 70124, Italy.
Lucia MiligiEnvironmental and Occupational Epidemiology Unit, Cancer Prevention and Research Institute (ISPO), Florence 50139, Italy.
Jacqueline Clavel1] Environmental Epidemiology of Cancer Group, Inserm, Centre for research in Epidemiology and Population Health (CESP), U1018, Villejuif F-94807, France [2] UMRS 1018, Univ Paris Sud, Villejuif F-94807, France.
Edward Giovannucci1] Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA [2] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA [3] Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Peter Kraft1] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA [2] Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Jarmo VirtamoDepartment of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki FI-00271, Finland.
Alex SmithDepartment of Health Sciences, University of York, York YO10 5DD, UK.
Eleanor KaneDepartment of Health Sciences, University of York, York YO10 5DD, UK.
Eve RomanDepartment of Health Sciences, University of York, York YO10 5DD, UK.
Brian C H ChiuDepartment of Health Studies, University of Chicago, Chicago, Illinois 60637, USA.
Joseph F FraumeniDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA.
Xifeng WuDepartment of Epidemiology, M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
James R CerhanDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA.
Kenneth OffitDepartment of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Stephen J ChanockDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA.
Nathaniel RothmanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA.
Alexandra NietersCenter For Chronic Immunodeficiency, University Medical Center Freiburg, Freiburg 79108, Germany.
Division of Cancer Epidemiology and GeneticsMemorial Sloan Kettering Cancer Center · USHarvard University · USMayo Clinic · USNational Cancer Institute · USUniversity of York · GBThe University of Texas MD Anderson Cancer Center · USAmerican Cancer Society · USBC Cancer Agency · CACentre International de Recherche sur le Cancer · FRFred Hutch Cancer Center · USImperial College London · GBMayo Clinic in Florida · USStatens Serum Institut · DKUniversity Medical Center Utrecht · NLUniversity of Bari Aldo Moro · ITUniversity of California, San Francisco · USUniversity of Iowa · USUniversity of Sydney · AUWestat (United States) · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI STANLEY R. HAMILTON · 1985 to 2026
$86.3M
Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI DAVID L RIMM · 1985 to 2026
$85.0M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI TWOROGER, SHELLEY S · 2000 to 2019
$77.8M
The Role of Monocytes in non-Hodgkin LymphomaP50CA097274 · NCI · UNIVERSITY OF IOWA · PI WEINER, GEORGE J. · 2002 to 2021
$45.7M
Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
RESEARCH IN ENVIRONMENTAL HEALTH SCIENCES (CENTER GRANT)P30ES000260 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COSTA, MAX · 1985 to 2020
$26.1M
CALIFORNIA'S PARTICIPATION IN THE NATIONAL CANCER PREVENTION AND CONTRO PROGRAMU58DP000807 · DP · PUBLIC HEALTH INSTITUTE · PI SNIPES, KURT P · 2007 to 2011
$22.5M
CCR NIH HHS N01 RC037004CCR NIH HHS N01-RC-45035CIHRIntramural NIH HHSNCATS NIH HHS UL1 TR000135NCATS NIH HHS UL1 TR000142NCATS NIH HHS UL1 TR000430NCCDPHP CDC HHS #1U58 DP000807-01NCCDPHP CDC HHS U58 DP000807NCI NIH HHS 5R01 CA69669-02NCI NIH HHS CA098122NCI NIH HHS CA098566NCI NIH HHS CA149445NCI NIH HHS CA167552NCI NIH HHS CA49449NCI NIH HHS CA87969NCI NIH HHS CA97274NCI NIH HHS HHSN261201000034CNCI NIH HHS HHSN261201000035CNCI NIH HHS HHSN261201000035INCI NIH HHS HHSN261201000140CNCI NIH HHS K07 CA115687NCI NIH HHS N01 CN045165NCI NIH HHS N01 CO012400NCI NIH HHS N01 PC065064NCI NIH HHS N01 PC067008NCI NIH HHS N01 PC067009NCI NIH HHS N01 PC067010NCI NIH HHS N01-PC-67009NCI NIH HHS N02-PC-71105NCI NIH HHS P01 CA087969NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA015083NCI NIH HHS P30 CA016087NCI NIH HHS P30 CA016672NCI NIH HHS P30 CA033572NCI NIH HHS P50 CA097274NCI NIH HHS P50 CA97274NCI NIH HHS R01 CA049449NCI NIH HHS R01 CA062006NCI NIH HHS R01 CA092153NCI NIH HHS R01 CA098122NCI NIH HHS R01 CA098661NCI NIH HHS R01CA1046282NCI NIH HHS R01 CA129539NCI NIH HHS R01 CA149445NCI NIH HHS R01 CA154643NCI NIH HHS R01CA154643NCI NIH HHS R21 CA178800NCI NIH HHS R25 CA098566NCI NIH HHS U01 CA049449NCI NIH HHS U01 CA167552NCI NIH HHS UM1 CA167552NCI NIH HHS UM1 CA182934NHGRI NIH HHS U01 HG007033NHLBI NIH HHS HHSN268201100001INHLBI NIH HHS HHSN268201100002INHLBI NIH HHS HHSN268201100003INHLBI NIH HHS HHSN268201100004INHLBI NIH HHS HHSN268201100046CNIA NIH HHS HHSN271201100004CNIEHS NIH HHS ES000260NIEHS NIH HHS P30 ES000260WHI NIH HHS HHSN268201100001CWHI NIH HHS HHSN268201100002CWHI NIH HHS HHSN268201100003CWHI NIH HHS HHSN268201100004CWorld Health Organization 001
6 · The paper itself

Abstract

Marginal zone lymphoma (MZL) is the third most common subtype of B-cell non-Hodgkin lymphoma. Here we perform a two-stage GWAS of 1,281 MZL cases and 7,127 controls of European ancestry and identify two independent loci near BTNL2 (rs9461741, P=3.95 × 10(-15)) and HLA-B (rs2922994, P=2.43 × 10(-9)) in the HLA region significantly associated with MZL risk. This is the first evidence that genetic variation in the major histocompatibility complex influences MZL susceptibility.

Indexed as

ButyrophilinsComputational BiologyGenome-Wide Association StudyGenotypeHumansLymphoma, B-Cell, Marginal ZoneMajor Histocompatibility ComplexMembrane GlycoproteinsPolymorphism, Single NucleotideWhite PeopleBTNL2 protein, humanButyrophilinsMembrane Glycoproteins

Identifiers

PMID25569183
PMCPMC4287989
OpenAlexW2105786909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.